(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification Number) | ||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||
( | ||||||||
(Registrant's telephone number, including area code) | ||||||||
| Not applicable | ||||||||
(Former name or former address, if changed since last report.) | ||||||||
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
Via Transportation, Inc. | ||||||||
Dated: August 6, 2026 | By: | /s/ Daniel Ramot | ||||||
| Name: | Daniel Ramot | |||||||
| Title: | Chief Executive Officer (Principal Executive Officer) | |||||||

| Q2 2026 | Q2 2025 | Change | |||||||||||||||
| (in thousands, except percentages and customer count) | |||||||||||||||||
| Key Business Metrics: | |||||||||||||||||
Platform Annual Run-Rate Revenue (1) | $ | 542,828 | $ | 428,532 | 27 | % | |||||||||||
Customer Count (2) | 847 | 689 | 23 | % | |||||||||||||
| Financial Highlights: | |||||||||||||||||
| Revenue | $ | 135,707 | $ | 107,133 | 27 | % | |||||||||||
| Gross Profit | $ | 55,606 | $ | 41,951 | 33 | % | |||||||||||
Adjusted Gross Profit (3) | $ | 56,297 | $ | 42,331 | 33 | % | |||||||||||
Adjusted Gross Margin (3) | 41 | % | 40 | % | 1 | pt | |||||||||||
Adjusted EBITDA (3) | $ | (3,441) | $ | (9,055) | (62) | % | |||||||||||
Adjusted EBITDA Margin (3) | (3) | % | (8) | % | 5 | pts | |||||||||||
| Net Loss | $ | (19,556) | $ | (21,221) | (8) | % | |||||||||||
Adjusted Net Loss (3) | $ | (838) | $ | (9,196) | (91) | % | |||||||||||
| Net Loss per Share—Basic and Diluted | $ | (0.24) | $ | (1.65) | (85) | % | |||||||||||
Adjusted Net Loss per Share—Basic and Diluted (3) | $ | (0.01) | $ | (0.72) | (99) | % | |||||||||||
| Q3 2026 | FY 2026 | ||||||||||
| ($ in millions) | |||||||||||
| Platform Revenue | $137.6 - $138.2 | $550.0 - $553.0 | |||||||||
| YoY Growth % | 25.5% - 26.0% | 26.6% - 27.3% | |||||||||
Adjusted EBITDA (1) | ($4.5) - ($3.5) | ($12.5) - ($7.5) | |||||||||
Adjusted EBITDA Margin (1) | (3.3)% - (2.5)% | (2.3)% - (1.4)% | |||||||||
| Profitability | Q4 2026 Adj. EBITDA > $0 | ||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| ($ in thousands, except share and per share amounts) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Revenue | $ | 135,707 | $ | 107,133 | $ | 263,141 | $ | 205,775 | |||||||||||||||
Cost of revenue (1)(2) | 80,101 | 65,182 | 157,480 | 124,014 | |||||||||||||||||||
| Gross profit | 55,606 | 41,951 | 105,661 | 81,761 | |||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
Research and development (1) | 26,108 | 22,737 | 50,636 | 44,083 | |||||||||||||||||||
Sales and marketing (1) | 21,142 | 15,973 | 41,632 | 31,175 | |||||||||||||||||||
General and administrative (1)(2) | 30,110 | 19,351 | 58,731 | 39,837 | |||||||||||||||||||
| Total operating expenses | 77,360 | 58,061 | 150,999 | 115,095 | |||||||||||||||||||
| Operating loss | (21,754) | (16,110) | (45,338) | (33,334) | |||||||||||||||||||
| Interest income | 2,799 | 487 | 5,578 | 1,054 | |||||||||||||||||||
| Interest expense | (282) | (2,419) | (511) | (4,825) | |||||||||||||||||||
| Other income (expense)—net | (154) | (2,307) | 1,288 | 1,211 | |||||||||||||||||||
Loss before provision for income taxes | (19,391) | (20,349) | (38,983) | (35,894) | |||||||||||||||||||
| Provision for income taxes | (165) | (872) | (722) | (1,644) | |||||||||||||||||||
| Net loss | $ | (19,556) | $ | (21,221) | $ | (39,705) | $ | (37,538) | |||||||||||||||
| Basic and diluted net loss per share: | |||||||||||||||||||||||
| Net loss per share—basic and diluted | $ | (0.24) | $ | (1.65) | $ | (0.49) | $ | (2.93) | |||||||||||||||
| Weighted average shares of common stock outstanding used in computing net loss per share—basic and diluted | 81,337,205 | 12,833,306 | 81,257,582 | 12,793,403 | |||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Cost of revenue | $ | 98 | $ | 37 | $ | 173 | $ | 106 | |||||||||||||||
| Research and development | 4,302 | 1,549 | 8,332 | 3,163 | |||||||||||||||||||
| Sales and marketing | 3,623 | 1,271 | 6,951 | 2,539 | |||||||||||||||||||
| General and administrative | 7,987 | 1,805 | 16,118 | 3,545 | |||||||||||||||||||
| Total | $ | 16,010 | $ | 4,662 | $ | 31,574 | $ | 9,353 | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Cost of revenue | $ | 593 | $ | 343 | $ | 1,188 | $ | 854 | |||||||||||||||
| General and administrative | 787 | 812 | 1,604 | 1,600 | |||||||||||||||||||
| Total | $ | 1,380 | $ | 1,155 | $ | 2,792 | $ | 2,454 | |||||||||||||||
| ($ in thousands) | June 30, 2026 | December 31 2025 | |||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ | 335,915 | $ | 370,914 | |||||||
Accounts receivable—net of allowance of $20 and $24 as of June 30, 2026 and December 31, 2025, respectively | 104,679 | 81,572 | |||||||||
| Prepaid expenses and other current assets | 17,612 | 17,065 | |||||||||
| Total current assets | 458,206 | 469,551 | |||||||||
| Noncurrent assets: | |||||||||||
| Restricted cash and cash equivalents | 1,301 | 1,171 | |||||||||
| Property and equipment—net | 16,051 | 13,395 | |||||||||
| Operating lease right-of-use assets | 17,085 | 18,319 | |||||||||
| Deferred tax assets | 401 | 529 | |||||||||
| Intangible assets—net | 32,971 | 36,025 | |||||||||
| Goodwill | 190,720 | 192,305 | |||||||||
| Other noncurrent assets | 1,614 | 1,800 | |||||||||
| Total noncurrent assets | 260,143 | 263,544 | |||||||||
| Total assets | $ | 718,349 | $ | 733,095 | |||||||
| ($ in thousands) | June 30, 2026 | December 31, 2025 | |||||||||
| Liabilities and stockholders' equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | 6,039 | $ | 4,427 | |||||||
| Accrued expenses and other current liabilities | 23,859 | 24,886 | |||||||||
| Operating lease liabilities | 9,829 | 9,749 | |||||||||
| Deferred revenue | 22,810 | 26,893 | |||||||||
| Insurance payables | 15,329 | 15,144 | |||||||||
| Accrued compensation and benefits | 12,930 | 13,136 | |||||||||
| Total current liabilities | 90,796 | 94,235 | |||||||||
| Noncurrent liabilities: | |||||||||||
| Operating lease liabilities | 8,196 | 9,378 | |||||||||
| Deferred revenue | 1,048 | 1,746 | |||||||||
| Total noncurrent liabilities | 9,244 | 11,124 | |||||||||
| Total liabilities | 100,040 | 105,359 | |||||||||
| Stockholders' equity: | |||||||||||
| Preferred stock | — | — | |||||||||
Class A common stock | 1 | 1 | |||||||||
Class B common stock | — | — | |||||||||
Class C common stock | — | — | |||||||||
| Additional paid-in capital | 1,844,614 | 1,811,349 | |||||||||
| Accumulated other comprehensive income (loss) | 4,715 | 7,702 | |||||||||
| Accumulated deficit | (1,231,021) | (1,191,316) | |||||||||
| Total stockholders’ equity | 618,309 | 627,736 | |||||||||
| Total liabilities and stockholders' equity | $ | 718,349 | $ | 733,095 | |||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Operating activities: | |||||||||||||||||||||||
| Net loss | $ | (19,556) | $ | (21,221) | $ | (39,705) | $ | (37,538) | |||||||||||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||||||||||||||
| Depreciation and amortization | 2,380 | 2,061 | 4,779 | 4,343 | |||||||||||||||||||
| Stock-based compensation | 16,010 | 4,662 | 31,574 | 9,353 | |||||||||||||||||||
| Provision for deferred taxes | 36 | 15 | 128 | 50 | |||||||||||||||||||
| Noncash operating lease expense | 2,817 | 2,148 | 6,101 | 4,073 | |||||||||||||||||||
| Revaluation of warrants liability | — | — | — | (2,273) | |||||||||||||||||||
| Revaluation of convertible notes' embedded derivative feature | — | 3,074 | — | 4,095 | |||||||||||||||||||
| Amortization of convertible notes' discount | — | 1,710 | — | 3,328 | |||||||||||||||||||
| Changes in operating assets and liabilities: | |||||||||||||||||||||||
| Accounts receivable | (9,853) | (5,803) | (23,641) | (6,254) | |||||||||||||||||||
| Prepaid expenses and other assets | 562 | (742) | (441) | (1,279) | |||||||||||||||||||
| Accounts payable | (1,178) | 365 | 1,640 | 2,820 | |||||||||||||||||||
| Accrued expenses and other current liabilities | 1,831 | (165) | (1,913) | 2,393 | |||||||||||||||||||
| Operating lease liabilities | (2,296) | (1,710) | (5,853) | (4,174) | |||||||||||||||||||
| Deferred revenue | (1,374) | (1,602) | (4,607) | (2,585) | |||||||||||||||||||
| Accrued compensation and benefits | (470) | 340 | (88) | (302) | |||||||||||||||||||
| Insurance payables | 446 | 580 | 184 | 2,066 | |||||||||||||||||||
| Net cash used in operating activities | (10,645) | (16,288) | (31,842) | (21,884) | |||||||||||||||||||
| Investing activities: | |||||||||||||||||||||||
| Purchase of property and equipment | (389) | (595) | (678) | (983) | |||||||||||||||||||
| Capitalized internal-use software | (2,015) | (1,246) | (4,007) | (2,118) | |||||||||||||||||||
| Acquisitions—net of cash acquired | 279 | — | 279 | — | |||||||||||||||||||
| Net cash used in investing activities | (2,125) | (1,841) | (4,406) | (3,101) | |||||||||||||||||||
| Financing activities: | |||||||||||||||||||||||
| Proceeds from issuance of Series E convertible preferred stock upon exercise of warrants | — | — | — | 20,000 | |||||||||||||||||||
| Repayment of line of credit | — | — | — | (5,000) | |||||||||||||||||||
| Proceeds from issuance of convertible notes | — | — | — | 7,500 | |||||||||||||||||||
| Proceeds from exercise of stock options | 695 | 1,374 | 1,691 | 2,054 | |||||||||||||||||||
| Payment of issuance fees | — | — | — | (322) | |||||||||||||||||||
| Net cash provided by financing activities | 695 | 1,374 | 1,691 | 24,232 | |||||||||||||||||||
| Effect of foreign exchange on cash, cash equivalents, and restricted cash and cash equivalents | (85) | 743 | (312) | 1,065 | |||||||||||||||||||
| Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents | (12,160) | (16,012) | (34,869) | 312 | |||||||||||||||||||
| Cash, cash equivalents, and restricted cash and cash equivalents—beginning of period | 349,376 | 95,313 | 372,085 | 78,989 | |||||||||||||||||||
| Cash, cash equivalents, and restricted cash and cash equivalents—end of period | $ | 337,216 | $ | 79,301 | $ | 337,216 | $ | 79,301 | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Gross profit | $ | 55,606 | $ | 41,951 | $ | 105,661 | $ | 81,761 | |||||||||||||||
| Gross profit margin | 41% | 39% | 40% | 40% | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | 98 | 37 | 173 | 106 | |||||||||||||||||||
Amortization of acquired intangibles (1) | 593 | 343 | 1,188 | 854 | |||||||||||||||||||
| Adjusted Gross Profit | $ | 56,297 | $ | 42,331 | $ | 107,022 | $ | 82,721 | |||||||||||||||
| Adjusted Gross Margin | 41% | 40% | 41% | 40% | |||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| Net loss | $ | (19,556) | $ | (21,221) | $ | (39,705) | $ | (37,538) | |||||||||||||||
| Interest Income | (2,799) | (487) | (5,578) | (1,054) | |||||||||||||||||||
| Interest expense | 282 | 2,419 | 511 | 4,825 | |||||||||||||||||||
| Provision for income taxes | 165 | 872 | 722 | 1,644 | |||||||||||||||||||
| Other (income) expense, net | 154 | 2,307 | (1,288) | (1,211) | |||||||||||||||||||
Depreciation and amortization (1) | 1,786 | 1,559 | 3,613 | 3,262 | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | 16,010 | 4,662 | 31,574 | 9,353 | |||||||||||||||||||
Patent litigation costs (2) | 62 | 717 | 200 | 2,693 | |||||||||||||||||||
Transaction costs (3) | 155 | 117 | 401 | 708 | |||||||||||||||||||
| Other | 300 | — | 300 | — | |||||||||||||||||||
| Adjusted EBITDA | $ | (3,441) | $ | (9,055) | $ | (9,250) | $ | (17,318) | |||||||||||||||
| Net loss margin | (14)% | (20)% | (15)% | (18)% | |||||||||||||||||||
| Adjusted EBITDA Margin | (3)% | (8)% | (4)% | (8)% | |||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| ($ in thousands) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| GAAP research and development expense | $ | 26,108 | $ | 22,737 | $ | 50,636 | $ | 44,083 | |||||||||||||||
| Depreciation | (104) | (135) | (217) | (276) | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | (4,302) | (1,549) | (8,332) | (3,163) | |||||||||||||||||||
| Adjusted Research and Development expense | $ | 21,702 | $ | 21,053 | $ | 42,087 | $ | 40,644 | |||||||||||||||
| GAAP sales and marketing expense | $ | 21,142 | $ | 15,973 | $ | 41,632 | $ | 31,175 | |||||||||||||||
| Stock-based compensation and related employer payroll taxes | (3,623) | (1,271) | (6,951) | (2,539) | |||||||||||||||||||
Transaction costs (1) | — | (4) | (32) | (4) | |||||||||||||||||||
| Other | $ | (275) | $ | — | $ | (275) | $ | — | |||||||||||||||
| Adjusted Sales and Marketing expense | $ | 17,244 | $ | 14,698 | $ | 34,374 | $ | 28,632 | |||||||||||||||
| GAAP general and administrative expense | $ | 30,110 | $ | 19,351 | $ | 58,731 | $ | 39,837 | |||||||||||||||
| Depreciation and amortization | (1,089) | (1,081) | (2,208) | (2,132) | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | (7,987) | (1,805) | (16,118) | (3,545) | |||||||||||||||||||
Patent litigation costs (2) | (62) | (717) | (200) | (2,693) | |||||||||||||||||||
Transaction costs (1) | (155) | (113) | (369) | (704) | |||||||||||||||||||
| Other | $ | (25) | $ | — | $ | (25) | $ | — | |||||||||||||||
| Adjusted General and Administrative expense | $ | 20,792 | $ | 15,635 | $ | 39,811 | $ | 30,763 | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| ($ in thousands, except share and per share amounts) | 2026 | 2025 | 2026 | 2025 | |||||||||||||||||||
| GAAP net loss | $ | (19,556) | $ | (21,221) | $ | (39,705) | $ | (37,538) | |||||||||||||||
| Amortization of discount on convertible notes | — | 1,710 | — | 3,328 | |||||||||||||||||||
| Revaluation of warrants liability | — | — | — | (2,273) | |||||||||||||||||||
| Revaluation of convertible notes embedded derivative feature | — | 3,074 | — | 4,095 | |||||||||||||||||||
| Employee retention credit | — | — | (1,758) | (1,811) | |||||||||||||||||||
Depreciation and amortization (1) | 1,786 | 1,559 | 3,613 | 3,262 | |||||||||||||||||||
| Stock-based compensation and related employer payroll taxes | 16,010 | 4,662 | 31,574 | 9,353 | |||||||||||||||||||
Patent litigation costs (2) | 62 | 717 | 200 | 2,693 | |||||||||||||||||||
Transaction costs (3) | 155 | 117 | 401 | 708 | |||||||||||||||||||
| Other | 300 | — | 300 | — | |||||||||||||||||||
| Provision for income tax benefit of adjustments | 405 | 186 | 766 | 374 | |||||||||||||||||||
| Adjusted Net Loss | $ | (838) | $ | (9,196) | $ | (4,609) | $ | (17,809) | |||||||||||||||
| GAAP net loss per share—basic and diluted | $ | (0.24) | $ | (1.65) | $ | (0.49) | $ | (2.93) | |||||||||||||||
| Adjusted Net Loss per share—basic and diluted | $ | (0.01) | $ | (0.72) | $ | (0.06) | $ | (1.39) | |||||||||||||||
| Weighted average shares of common stock outstanding used in computing net loss per share and Adjusted Net Loss per share—basic and diluted | 81,337,205 | 12,833,306 | 81,257,582 | 12,793,403 | |||||||||||||||||||